Jonathan M. Hand

Dr. Jonathan M. Hand


Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 March 2019 in Clinical Transplantation
Verified
Journal Article
Closed access
PDF file
RMRebecca Pellett Madan
Rebecca Pellett Madan
JHJonathan M. Hand
Jonathan M. Hand
TPthe AST Infectious Diseases Community of Practice
the AST Infectious Diseases Community of Practice

2 August 2021 in American Journal of Transplantation
Verified
Journal Article
Open access
MSMiranda So
Miranda So
JHJonathan M. Hand
Jonathan M. Hand
GFGraeme Forrest
Graeme Forrest
SPStephanie M. Pouch
Stephanie M. Pouch
HTHelen Te
Helen Te
SHShahid Husain
Shahid Husain
Antimicrobial stewardship programs (ASPs) have made immense strides in optimizing antibiotic, antifungal, and antiviral use in clinical settings. However, although ASPs are required institutionally by regulatory agencies in the United States and Canada, they are not mandated for transplant centers or programs specifically. Despite the fact that solid organ transplant recipients in particular are at increased risk of infections from multidrug-resistant organisms, due to host and donor factors and immunosuppressive therapy, there currently are little rigorous data regarding stewardship practices in solid organ transplant populations, and thus, no transplant-specific requirements currently exist. Further complicating matters, transplant patients have a wide range of variability regarding their susceptibility to infection, as factors such as surgery of transplant, intensity of immunosuppression, and presence of drains or catheters in situ may modify the risk of infection. As such, it is not feasible to have a "one-size-fits-all" style of stewardship for this patient population. The objective of this white paper is to identify opportunities, risk factors, and ASP strategies that should be assessed with solid organ transplant recipients to optimize antimicrobial use, while producing an overall improvement in patient outcomes. We hope it may serve as a springboard for development of future guidance and identification of research opportunities.

13 February 2019 in BMJ Open Quality
Verified
Journal Article
Open access
PDF file
RMRichard V Milani
Richard V Milani
JWJonathan K Wilt
Jonathan K Wilt
JEJonathan Entwisle
Jonathan Entwisle
JHJonathan M. Hand
Jonathan M. Hand
PCPedro Cazabon
Pedro Cazabon
JBJefferson G Bohan
Jefferson G Bohan
Importance Antibiotic resistance is a global health issue. Up to 50% of antibiotics are inappropriately prescribed, the majority of which are for acute respiratory tract infections (ARTI). Objective To evaluate the impact of unblinded normative comparison on rates of inappropriate antibiotic prescribing for ARTI. Design Non-randomised, controlled interventional trial over 1 year followed by an open intervention in the second year. Setting Primary care providers in a large regional healthcare system. Participants The test group consisted of 30 primary care providers in one geographical region; controls consisted of 162 primary care providers located in four other geographical regions. Intervention The intervention consisted of provider and patient education and provider feedback via biweekly, unblinded normative comparison highlighting inappropriate antibiotic prescribing for ARTI. The intervention was applied to both groups during the second year. Main outcomes and measures Rate of inappropriate antibiotic prescription for ARTI. Results Baseline inappropriate antibiotic prescribing for ARTI was 60%. After 1 year, the test group rate of inappropriate antibiotic prescribing decreased 40%, from 51.9% to 31.0% (p<0.0001), whereas controls decreased 7% (61.3% to 57.0%, p<0.0001). In year 2, the test group decreased an additional 47% to an overall prescribing rate of 16.3%, and the control group decreased 40% to a prescribing rate of 34.5% after implementation of the same intervention. Conclusions and relevance Provider and patient education followed by regular feedback to provider via normative comparison to their local peers through unblinded provider reports, lead to reductions in the rate of inappropriate antibiotic prescribing for ARTI and overall antibiotic prescribing rates.

14 January 2014 in AIDS
Verified
Journal Article
Open access
MGMichael Gaisa
Michael Gaisa
KSKeith Sigel
Keith Sigel
JHJonathan M. Hand
Jonathan M. Hand
SGStephen Goldstone
Stephen Goldstone
Objective: To determine rates of anal dysplasia in a cohort of HIV-infected men who have sex with men (MSM), women, and heterosexual men with abnormal anal cytology. Design/methods: We evaluated histologic findings in 728 HIV-infected MSM, women, and heterosexual men referred for high-resolution anoscopy (HRA) after abnormal anal cytology in a single-center cohort study. Using multivariable logistic regression, we evaluated predictors of high-grade squamous intraepithelial lesion (HSIL) histology or invasive carcinoma including age, sexual behavior, receptive anal intercourse (RAI), anogenital warts, smoking status, antiretroviral therapy, CD4+ T-cell count, and HIV-1 plasma viral load. Results: A total of 2075 HIV-positive patients were screened with anal cytology and 62% of MSM, 42% of women, and 29% of heterosexual men had abnormal findings (P <0.001). Of the 728 HIV-infected patients with abnormal anal cytology who underwent HRA, 71% were MSM, 23% women, and 6% heterosexual men. HSIL/cancer was found in 32% of MSM, 26% of women, and 23% of heterosexual men (P = 0.3). There were five cases of anal squamous cell carcinoma (0.7%), four in MSM and one in a heterosexual man. In a multivariable adjusted analysis, biopsy-proven HSIL/cancer was associated with RAI [odds ratio (OR) 2.2; 95% confidence interval (CI) 1.3–3.7]. CD4+ T-cell counts more than 500/μl conferred a lower risk of HSIL/cancer (OR 0.5; 95% CI 0.3–0.9). Conclusion: Rates of anal HSIL histology are high in HIV-infected patients of all sexual risk groups with abnormal anal cytology. Consequently, all HIV-infected patients may warrant anal cancer screening.

26 July 2016 in Liver Transplantation
Verified
Journal Article
Closed access
PDF file
JHJonathan M. Hand
Jonathan M. Hand
GPGopi Patel
Gopi Patel

22 September 2014 in American Journal of Transplantation
Verified
Journal Article
Open access
PDF file
DAD. R. Altman
D. R. Altman
RSR. Sebra
R. Sebra
JHJonathan M. Hand
Jonathan M. Hand
OAO. Attie
O. Attie
GDG. Deikus
G. Deikus
SHS. Huprikar
S. Huprikar
Donor‐derived bacterial infection is a recognized complication of solid organ transplantation (SOT). The present report describes the clinical details and successful outcome in a liver transplant recipient despite transmission of methicillin‐resistant Staphylococcus aureus (MRSA) from a deceased donor with MRSA endocarditis and bacteremia. We further describe whole genome sequencing (WGS) and complete de novo assembly of the donor and recipient MRSA isolate genomes, which confirms that both isolates are genetically 100% identical. We propose that similar application of WGS techniques to future investigations of donor bacterial transmission would strengthen the definition of proven bacterial transmission in SOT, particularly in the presence of highly clonal bacteria such as MRSA. WGS will further improve our understanding of the epidemiology of bacterial transmission in SOT and the risk of adverse patient outcomes when it occurs.